Sharps Stock (NASDAQ:STSS)

Revenue Ownership Financials Chart

Previous Close

$2.00

52W Range

$1.42 - $18.23

50D Avg

$1.79

200D Avg

$3.87

Market Cap

$53.33M

Avg Vol (3M)

$333.02K

Beta

2.02

Div Yield

STSS Company Profile

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Apr 14, 2022

Website

STSS Performance

STSS Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$204.12K	-	-
Operating Income	$-269.74M	$-7.86M	$-10.13M
Net Income	$-282.50M	$-9.30M	$-9.84M
EBITDA	$-269.74M	$-6.85M	$-8.98M
Basic EPS	$-11.16	$-2.22K	$-4.98K
Diluted EPS	$-11.16	$-2.22K	$-4.98K

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

Ticker	Company
CCLD	CareCloud, Inc.
MBOT	Microbot Medical Inc.
PDEX	Pro-Dex, Inc.
RPID	Rapid Micro Biosystems, Inc.
GLSI	Greenwich LifeSciences, Inc.
CGTX	Cognition Therapeutics, Inc.
SERA	Sera Prognostics, Inc.
LUCD	Lucid Diagnostics Inc.
IXHL	Incannex Healthcare Limited
JYNT	The Joint Corp.